D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
976
Stantec
STN
$8.18B
| $30.1M | 0.01% |
437,000
+132,400
| +43% | +$10.7M |
2024 Q3
7 quarters
|
|
977
CALL
Bunge Global
BG
$19.8B
| $30.1M | 0.01% |
281,600
+167,800
| +147% | +$20.6M |
2019 Q1
29 quarters
|
|
978
CALL
Blackrock
BLK
$176B
| $30M | 0.01% |
31,200
-3,500
| -10% | -$3.62M |
2017 Q4
34 quarters
|
|
979
Taysha Gene Therapies
TSHA
$1.3B
| $30M | 0.01% |
4,398,652
-28,649
| -0.6% | -$170K |
2025 Q2
4 quarters
|
|
980
Borr Drilling
BORR
$1.26B
| $29.9M | 0.01% |
7,248,907
+1,007,405
| +16% | +$5.44M |
2025 Q4
2 quarters
|
|
981
CALL
Constellation Energy
CEG
$90.4B
| $29.8M | 0.01% |
+119,800
| New | +$33.7M |
2026 Q2
0 quarters
|
|
982
MGIC Investment
MTG
$5.69B
| $29.6M | 0.01% |
1,050,927
+160,497
| +18% | +$4.28M |
2021 Q3
19 quarters
|
|
983
CoStar Group
CSGP
$14.4B
| $29.5M | 0.01% |
1,043,332
-4,866,291
| -82% | -$167M |
2021 Q4
18 quarters
|
|
984
Manulife Financial
MFC
$75.5B
| $29.5M | 0.01% |
728,603
+310,256
| +74% | +$12M |
2025 Q2
4 quarters
|
|
985
TORM
TRMD
$3.96B
| $29.5M | 0.01% |
1,132,130
+529,237
| +88% | +$16M |
2025 Q4
2 quarters
|
|
986
Royalty Pharma
RPRX
$28.4B
| $29.4M | 0.01% |
525,114
-596,933
| -53% | -$31.1M |
2024 Q2
8 quarters
|
|
987
CALL
Occidental Petroleum
OXY
$62.5B
| $29.4M | 0.01% |
605,600
+252,500
| +72% | +$14.3M |
2018 Q1
33 quarters
|
|
988
CALL
Akamai
AKAM
$13.1B
| $29.3M | 0.01% |
+248,000
| New | +$30.9M |
2026 Q2
0 quarters
|
|
989
REX American Resources
REX
$1.32B
| $29.2M | 0.01% |
646,597
+2,702
| +0.4% | +$125K |
2023 Q4
10 quarters
|
|
990
CALL
Amgen
AMGN
$242B
| $29.2M | 0.01% |
80,500
-16,000
| -17% | -$5.48M |
2022 Q4
14 quarters
|
|
991
Arvinas
ARVN
$505M
| $29M | 0.01% |
3,495,153
-143,414
| -4% | -$1.34M |
2025 Q2
4 quarters
|
|
992
Plexus
PLXS
$5.88B
| $29M | 0.01% |
96,425
-67,522
| -41% | -$17.6M |
2013 Q4
50 quarters
|
|
993
UBS Group
UBS
$144B
| $28.9M | 0.01% |
583,637
-734,317
| -56% | -$33.4M |
2024 Q2
8 quarters
|
|
994
Toast
TOST
$19.3B
| $28.9M | 0.01% |
1,039,379
-1,372,016
| -57% | -$35.8M |
2024 Q4
6 quarters
|
|
995
CALL
Enphase Energy
ENPH
$4.14B
| $28.9M | 0.01% |
586,700
+476,800
| +434% | +$21.7M |
2020 Q1
25 quarters
|
|
996
Valaris
VAL
$6.4B
| $28.8M | 0.01% |
396,996
+60,775
| +18% | +$5.66M |
2025 Q3
3 quarters
|
|
997
Everpure Inc
P
$40.4B
| $28.8M | 0.01% |
365,682
-272,714
| -43% | -$20M |
2017 Q3
35 quarters
|
|
|
998
PUT
Occidental Petroleum
OXY
$62.5B
| $28.8M | 0.01% |
592,800
-594,700
| -50% | -$33.8M |
2017 Q1
37 quarters
|
|
999
Columbia Banking Systems
COLB
$8.46B
| $28.8M | 0.01% |
+897,711
| New | +$26.7M |
2026 Q2
0 quarters
|
|
1000
Honda
HMC
$44.9B
| $28.6M | 0.01% |
1,055,372
+290,978
| +38% | +$7.4M |
2026 Q1
1 quarter
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.